Jpmorgan Chase & CO Cumberland Pharmaceuticals Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPIX
# of Institutions
23Shares Held
1.97MCall Options Held
44.2KPut Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny528KShares$565,1340.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$400,4480.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX287KShares$306,7200.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX284KShares$303,8850.0% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$201,3350.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $15.7M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...